BioSpace News Archive

New Patent for Know Labs Marks Latest Step Toward Commercial Launch of Bio-RFID TM Non-Invasive Medical Diagnostic Technology

The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a clinical practice guideline focusing on management of the toxicities called immune-related adverse events that can affect cancer patients treated with immune checkpoint inhibitors (ICIs).

Tidal Medical Technologies today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for emergency use of the InSee incentive spirometer accessory for quantitatively tracking patient usage of Vyaire Medical’s AirLife incentive spirometer, as an aid in treatment of respiratory conditions by patients with Coronavirus Disease 2019 (COVID-19) in hospital settings.

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Ascentage Pharma (6855.HK), today announced a multifaceted strategic collaboration.

Inovalon today announced that it will hold a conference call for investors on Wednesday, July 28, 2021, at 5:00 p.m. Eastern Time.

Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis.

BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced changes to its board of directors.

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced it will participate in two investor conferences: the BTIG Virtual Biotechnology Conference on August 9th and 10th and the Canaccord Growth Conference on August 11th and 12th.

Iterion Therapeutics, Inc., a venture-backed, clinical-stage biotechnology company developing novel cancer therapeutics, today announced the appointment of Jean Chang to the position of Chief Operating Officer.

Kriya Therapeutics, Inc. today announced the closing of a $100 Million Series B financing to support its mission of transforming the design, development and manufacturing of gene therapies.